Gojo, Ivana <br/><br/>
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2017 
 - 697-706 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-16-0984  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Benzimidazoles--administration & dosage<br/>DNA Methylation--drug effects<br/>DNA Modification Methylases--genetics<br/>DNA Repair Enzymes--genetics<br/>Dacarbazine--administration & dosage<br/>Drug Synergism<br/>Esophagitis--chemically induced<br/>Female<br/>Histones--metabolism<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Leukemia, Myelomonocytic, Chronic--drug therapy<br/>Male<br/>Middle Aged<br/>Mucositis--chemically induced<br/>Neoplasm Proteins--analysis<br/>Phosphorylation--drug effects<br/>Poly (ADP-Ribose) Polymerase-1--analysis<br/>Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage<br/>Promoter Regions, Genetic--drug effects<br/>Protein Processing, Post-Translational--drug effects<br/>Remission Induction<br/>Salvage Therapy<br/>Temozolomide<br/>Tumor Suppressor Proteins--genetics<br/>Young Adult